Debt Facility will fund further growth ambitions and advancement in embedded payments capabilities Oxford Finance backs Sokin’s profitable growth and global expansion Company maintains 100% year-on-year revenue growth while remaining … Continued
ALEXANDRIA, Va.–(BUSINESS WIRE)–Oxford Finance LLC (“Oxford”), a leading specialty finance firm, is proud to announce the successful closing of its first transaction under its recently launched Asset-Based Lending (ABL) Division … Continued
$1.8+ Billion in Capital Deployed 29 New Platform Transactions 15 New Sponsor Relationships 7 Credit Facility Upsizes 50+ DDTL Fundings to Existing Borrowers Oxford’s Leveraged Lending Group had a … Continued
EMERYVILLE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Kyverna Therapeutics, Inc. (Nasdaq: KYTX) (“Kyverna”), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that, … Continued
$1.4+ Billion in New Capital Commitments 20 New Platform Transactions 12 New Sponsor Relationships 5 Credit Facility Upsizes 30+ DDTL Fundings to Existing Borrowers SELECT Q3-2025 TRANSACTIONS: September 2025: Oxford … Continued
ALEXANDRIA, Va.– Oxford Finance LLC (“Oxford” or the “Company”), a leading specialty finance firm, is pleased to announce the appointment of Brock Johnson to lead Underwriting for its newly created … Continued
